The following data is part of a premarket notification filed by Ascensia Diabetes Care with the FDA for Contour® Next One Blood Glucose Monitoring System.
| Device ID | K210687 |
| 510k Number | K210687 |
| Device Name: | CONTOUR® NEXT ONE Blood Glucose Monitoring System |
| Classification | System, Test, Blood Glucose, Over The Counter |
| Applicant | Ascensia Diabetes Care 100 Summit Lake Drive Valhalla, NY 10595 |
| Contact | Stacie Geffner-atiya |
| Correspondent | Stacie Geffner-atiya Ascensia Diabetes Care 100 Summit Lake Drive Valhalla, NY 10595 |
| Product Code | NBW |
| CFR Regulation Number | 862.1345 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Special |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2021-03-08 |
| Decision Date | 2021-08-11 |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 40301937825017 | K210687 | 000 |
| 40301939550016 | K210687 | 000 |
| 40301937828018 | K210687 | 000 |